IBB logo

iShares NASDAQ Biotechnology ETF (IBB)

$206.97

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on IBB

AUM

$10.69B

P/E ratio

25.6

Dividend yield

0.1559%

Expense ratio

0.44%

Beta

0.720408

Price on IBB

Previous close

$207.98

Today's open

$207.47

Day's range

$204.57 - $208.10

52 week range

$159.68 - $222.29

Profile about IBB

show more

Headquarters

US

Exchange

NASDAQ Global Market

Issue type

Exchange-Traded Fund

IBB industries and sectors

Industries

Health

Top holdings in IBB
News on IBB

Which Healthcare ETF Is the Better Buy: State Street's Pharma Fund XPH or iShares' Biotech Fund IBB?

State Street SPDR S&P Pharmaceuticals ETF has a lower expense ratio and a higher trailing dividend yield. iShares Biotechnology ETF is significantly larger by assets under management.

news source

The Motley Fool • Nov 15, 2026

news preview

Which Healthcare ETF Is the Better Buy: VanEck's Pharma Fund PPH or iShares' Biotech Fund IBB?

VanEck Pharmaceutical ETF offers a lower expense ratio and a higher dividend yield than iShares Biotechnology ETF. iShares Biotechnology ETF provides broader exposure with over 200 holdings, while VanEck Pharmaceutical ETF concentrates on 26 pharmaceutical leaders.

news source

The Motley Fool • Nov 15, 2026

news preview

Two Ways to Play Biotech: FBT's Return Edge vs. IBB's Cost Advantage

First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio of 30 holdings compared to the 243 positions found in iShares Biotechnology ETF. iShares Biotechnology ETF carries a lower expense ratio of 0.44% whereas First Trust NYSE Arca Biotechnology Index Fund charges 0.55%.

news source

The Motley Fool • Nov 14, 2026

news preview

Choosing Healthcare ETFs: Why IHE Outperforms IBB for Many Investors

The iShares U.S. Pharmaceuticals ETF offers a lower expense ratio and a significantly higher dividend yield than the iShares Biotechnology ETF. The iShares Biotechnology ETF provides exposure to a broader group of 243 companies, while the iShares U.S. Pharmaceuticals ETF is concentrated in only 53 holdings.

news source

The Motley Fool • Nov 7, 2026

news preview

Democrats Sweep Midterms: What It Means For Pharma And Biotech Holdings (Stocks To Watch)

U.S. midterm results signal a "Blue Wave," with Democrats controlling both House and Senate, likely impacting healthcare policy and funding. Health insurers like UnitedHealth and CVS Health typically rebound after policy shocks; Oscar Health stands out for ACA-driven growth and innovation.

news source

Seeking Alpha • Nov 5, 2026

news preview

How to Invest in the Rise of China's Biotech: Buy U.S. Drug Stocks

Many of the hot new drug candidates in the U.S. were developed Chinese companies.

news source

Barrons • Nov 3, 2026

news preview

Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?

Designed to provide broad exposure to the Health Care ETFs category of the market, the iShares Biotechnology ETF (IBB) is a smart beta exchange traded fund launched on 02/05/2001.

news source

Zacks Investment Research • Nov 2, 2026

news preview

$10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09%

A single health care ETF launched two decades ago at rock-bottom cost has quietly compounded into a sum that surprises most investors, but whether its three closest rivals can match it depends entirely on what kind of risk you are

news source

24/7 Wall Street • Oct 31, 2026

news preview

Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs

Regeneron (NASDAQ:REGN | REGN Price Prediction) shares rose 13.55% in Friday's session, trading at $929.69 as of 9:45 AM ET on Oct 30, 2026. For a biotech worth roughly $94.

news source

24/7 Wall Street • Oct 30, 2026

news preview

Should You Invest in the iShares Biotechnology ETF (IBB)?

Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.

news source

Zacks Investment Research • Oct 29, 2026

news preview

¹ Disclosures

Get started with M1

Invest in iShares NASDAQ Biotechnology ETF

Open an M1 investment account to buy and sell iShares NASDAQ Biotechnology ETF commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in IBB on M1